Brief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
06/10/2026 12:55
BRIEF-Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil Oct 6 (Reuters) - Knight Therapeutics Inc GUD.TO:
KNIGHT THERAPEUTICS ANNOUNCES REGULATORY APPROVAL OF NIKTIMVO® IN BRAZIL
Source text: ID:nGNX5R3hZw
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Incyte
See all newsUS RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Syndax says mid-stage trial of lung disease treatment fails main goal, ends development
Brief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil